Oral administration of LPS and lipoteichoic acid prepartum modulated reactants of innate and humoral immunity in periparturient dairy cows

Innate Immunity

Volumn 20, Issue 4, 2014, Pages 390-400

  Iqbal, Summera ^a   Zebeli, Qendrim ^b   Mansmann, Dominik A ^a   Dunn, Suzanna M ^a   Ametaj, Burim N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Institute of Animal Nutrition and Functional Plant Compounds   (Austria)

Author keywords

innate and humoral immunity; lipopolysaccharide; lipoteichoic acid; Oral

Indexed keywords

ACUTE PHASE PROTEIN; ENDOTOXIN; HAPTOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIPOTEICHOIC ACID; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA; CARRIER PROTEIN; IMMUNOGLOBULIN; LIPOPOLYSACCHARIDE-BINDING PROTEIN; MEMBRANE PROTEIN; TEICHOIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BACILLUS SUBTILIS; BACTERIAL CELL WALL; BLOOD SAMPLING; CONTROLLED STUDY; DAIRY CATTLE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; FOOD INTAKE; HOLSTEIN CATTLE; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; MILK PRODUCTION; MUCOSAL IMMUNITY; NONHUMAN; PERINATAL PERIOD; PROTEIN BLOOD LEVEL; SALIVA ANALYSIS; SALIVA LEVEL; ANIMAL; BLOOD; BOVINAE; CATTLE DISEASES; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; ORAL DRUG ADMINISTRATION; PREGNANCY;

ACUTE-PHASE PROTEINS; ADMINISTRATION, ORAL; ANIMALS; BACILLUS SUBTILIS; CARRIER PROTEINS; CATTLE; CATTLE DISEASES; ESCHERICHIA COLI; FEMALE; HAPTOGLOBINS; IMMUNITY, HUMORAL; IMMUNITY, INNATE; IMMUNOGLOBULINS; IMMUNOMODULATION; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; PERIPARTUM PERIOD; PREGNANCY; SERUM AMYLOID A PROTEIN; TEICHOIC ACIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84898946270     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425913496125     Document Type: Article

References (37)

1. Mallard BA, Dekkers JC, Ireland MJ, et al. Alteration in immune responsiveness during the peripartum period and its ramification on dairy cow and calf health. J Dairy Sci. 1998 ; 81: 585-595
2. Goff JP, Horst RL. Physiological changes at parturition and their relationship to metabolic disorders. J Dairy Sci. 1997 ; 80: 1260-1268
3. Ametaj BN, Bradford BJ, Bobe G, et al. Strong relationships between mediators of the acute phase response and fatty liver in dairy cows. Can J Anim Sci. 2005 ; 85: 165-175
4. Lacetera N, Scalia D, Bernabucci U, et al. Lymphocyte functions in overconditioned cows around parturition. J Dairy Sci. 2005 ; 88: 2010-2016
5. Ametaj BN, Zebeli Q, Iqbal S. Nutrition, microbiota and endotoxin-related diseases in dairy cows. R Bras Zootec. 2010 ; 39: 433-444
6. Emmanuel DG, Dunn SM, Ametaj BN. Feeding high proportions of barley grain stimulates an inflammatory response in dairy cows. J Dairy Sci. 2008 ; 91: 606-614
7. Khafipour E, Li S, Plaizier JC, et al. Rumen microbiome composition determined using two nutritional models of subacute ruminal acidosis. Appl Environ Microbiol. 2009 ; 75: 7115-7124
8. Plaizier JC, Khafipour E, Li S, et al. Subacute ruminal acidosis (SARA), endotoxins and health consequences. Anim Feed Sci Technol. 2012 ; 172: 9-21
9. Krause DO, Smith WJM, Conlan LL, et al. Diet influences the ecology of lactic acid bacteria and Escherichia coli along the digestive tract of cattle: neural networks and 16S rDNA. Microbiol. 2003 ; 149: 57-65
10. Ametaj BN, Zebeli Q, Iqbal S, et al. Meeting the challenges of improving health in periparturient dairy cows. WCDS Ad Dairy Technol. 2012 ; 24: 287-317
11. Lamm ME. Interaction of Ags and Abs at mucosal surfaces. Ann Rev Microbiol. 1997 ; 51: 311-340
12. Medaglini D, Oggioni M, Pozzi G. Vaginal immunisation with recombinant gram-positive bacteria. Amer J Reprod Immunol. 1998 ; 39: 199-208
13. Brandtzaegss P. Secretory immunity with special reference to the oral cavity. J Oral Microbiol. :
14. Keren DF, McDonald RA, Carey JL. Combined parenteral and oral immunization results in an enhanced mucosal immunoglobulin A response to Shigella flexneri. Infect Immun. 1988 ; 56: 910-915
15. Ametaj BN, Sivaraman S, Dunn SM, et al. Repeated oral administration of lipopolysaccharide from Escherichia coli 0111:B4 modulated humoral immune responses in periparturient dairy cows. Innate Immun. 2012 ; 18: 638-647
16. Petzl W, Günther J, Pfister T, et al. Lipopolysaccharide pretreatment of the udder protects against experimental Escherichia coli mastitis. Innate Immunity. 2012 ; 18: 467-477
17. Rainard P, Fromageau A, Cunha P, et al. Staphylococcus aureu lipoteichoic acid triggers inflammation in the lactating bovine mammary gland. Vet Res. 2008 ; 39: 52-52
18. Daly KA, Mailer SL, Digby MR, et al. Molecular analysis of tammar (Macropus eugenii) mammary epithelial cells stimulated with lipopolysaccharide and lipoteichoic acid. Vet Immunol Immunopathol. 2009 ; 129: 36-48
19. Iqbal S, Zebeli Q, Mansmann DA, et al. Metabolic and clinical responses of dairy cows to increasing oral doses of lipoteichoic acid. J Anim Sci. 2011 ; 89 (E-Suppl. 1)/J Dairy Sci 94(E-Suppl. 1). 16-16
20. Nutrient requirements of dairy cattle. 7 th rev. ed. Washington, DC: National Academy of Science, 2001. Washington, DC: National Academy of Science ; 2001 :
21. Guide to the care and use of experimental animals. 1993 ; Vol. 1. 2nd ed. Ottawa, ON: CCAC. Ottawa, ON: CCAC ; 1993 :
22. Zebeli Q, Sivaraman S, Dunn SM, et al. Intermittent parenteral administration of endotoxin triggers metabolic and immunological alterations typically associated with displaced abomasum and retained placenta in periparturient dairy cows. J Dairy Sci. 2011 ; 94: 4968-4983
23. Mcdonald TL, Weber A, Smith JW. Monoclonal Ab sandwich immunoassay for serum amyloid A (SAA) protein. J Immunol Methods. 1991 ; 144: 149-155
24. Kumar H, Kawai T, Akira S. Pathogen recognition in the innate immune response. Biochem J. 2009 ; 420: 1-16
25. Dong G, Liu S, Wu Y, et al. Diet-induced bacterial immunogens in the gastrointestinal tract of dairy cows: impacts on immunity and metabolism. Acta Vet Scand. 2011 ; 53: 48-48
26. Lycke N. Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol. 2012 ; 12: 592-605
27. Vázquez-Padrón RI, Moreno-Fierros L, Neri-Bazán L, et al. Characterization of the mucosal and systemic immune response induced by Cry1Ac protein from Bacillus thuringiensis HD 73 in mice. Braz J Med Biol Res. 2000 ; 33: 147-155
28. Mestecky J, Russell MW, Elson CO. Perspectives on mucosal vaccines: is mucosal tolerance a barrier?. J Immunol. 2007 ; 179: 5633-5638
29. Bellmann K, Kolb H, Hartmann B, et al. Intervention in autoimmune diabetes by targeting the gut immune system. Int J Immunopharmacol. 1997 ; 19: 573-577
30. Challacombe SJ, Tomasi TB. Systemic tolerance and secretory immunity after oral immunization. J Exp Med. 1980 ; 152: 1459-1472
31. Bouvet JP, Fischetti VA. Diversity of Ab-mediated immunity at the mucosal barrier. Infect Immun. 1999 ; 67: 2687-2691
32. Defrance T, Taillardet M, Genestier L. T cell-independent B cell memory. Curr Opin Immunol. 2011 ; 23: 330-336
33. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999 ; 340: 448-454
34. Elsasser TH, Caperna TJ, Li CJ, et al. Critical control points in the impact of the proinflammatory immune response on growth and metabolism. J Anim Sci. 2008 ; 86: E105 - E125
35. Ametaj BN, Hosseini A, Odhiambo JF, et al Acute phase proteins as early non-specific biomarkers of human and veterinary diseases. Veas F, ed. InTech, 2001 ; 2011 :
36. Arredouani M, Matthijs P, Hoeyveld V, et al. Haptoglobin directly affects cells and suppresses T helper cell type 2 cytokine release. Immunol. 2003 ; 108: 144-151
37. Levels JH, Abraham PR, Van Den Ende A, et al. Distribution and kinetics of lipoprotein-bound endotoxin. Infect Immun. 2001 ; 69: 2821-2828